Time course of the effect of a bolus dose of intrathecal baclofen on severe cerebral spasticity

Journal of Neurology

Volumn 250, Issue 10, 2003, Pages 1195-1200

  Pohl, Marcus ^d   Rockstroh, Günter ^d   Rückriem, Stefan ^d   Mehrholz, Jan ^d   Pause, Max ^a   Koch, Rainer ^b   Strik, Herwig ^c  

^a Dept of Neurological Rehabilitation ^*  (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d Klinik Bavaria in Kreischa GmbH   (Germany)

Author keywords

Baclofen bolus test; Intrathecal baclofen; Measurement of spasticity; Muscle spasticity

Indexed keywords

BACLOFEN;

ADULT; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; FORCE; HUMAN; INFUSION PUMP; KNEE; MALE; PRIORITY JOURNAL; SPASTICITY; TECHNIQUE; TIME; TORQUE;

ADULT; BACLOFEN; BRAIN DISEASES; FEMALE; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; KNEE JOINT; MALE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0142106358     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-003-0178-1     Document Type: Article

References (25)

1. Ada L, Q'Dwyer N (2001)Do associated reactions in the upper limb after stroke contribute to contracture formation? Clin Rehabil 15:186-194
2. Barnes MP (2001) An overview of the clinical management of spasticity. In: Barnes MP, Johnson GR (eds) Upper motor neurone syndrome and spasticity: Clinical management and neurophysiology. Cambridge University Press, Cambridge, pp 1-11
3. Becher JG, Lankhorst GJ, van Bennekom CA, Vogelaar TW (1999) Measurement of the effect of a bolus dose of intrathecal baclofen by a repetitive movement test. J Neurol 246: 1080-1085
4. Channon EJ, McEntegart DJ (2001) Confidence intervals and p-values for Williams' and other step-down multiple comparison tests against control. J Biopharm Stat 11:45-63
5. Coffey RJ, Cahill D, Steers W, Park TS, Ordia J, Meythaler J, Herman R, Shetter AG, Levy R, Gill B, Smith R, Wilberger J, Loser JD, Chabel C, Feler C, Robertson JT, Penn RD, Clarke A, Burchiel KJ, Leibrock LG (1993) Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 78:226-232
6. Dressnandt J, Conrad B (1996) Lasting reduction of severe spasticity after ending chronic treatment with intrathecal baclofen. J Neurol Neurosurg Psychiatry 60:168-173
7. Hilsenbeck SG, Clark GM (1996) Practical p-value adjustment for optimally selected cutpoints. Stat Med 15: 103-112
8. Johnson GR (2001) Measurement of spasticity. In: Barnes MP, Johnson GR (eds) Upper motor neurone syndrome and spasticity: Clinical management and neurophysiology. Cambridge University Press, Cambridge, pp 79-95
9. Kamensek J (1999) Continuous intrathecal baclofen infusions. An introduction and overview. Axone 20:93-98
10. Kravitz HM, Corcos DM, Hansen G, Penn RD, Cartwright RD, Gianino J (1992) Intrathecal baclofen. Effects on nocturnal leg muscle spasticity. Am J Phys Med Rehabil 71:48-52
11. Masur H (2000) Skalen und Scores in der Neurologie. Thieme Verlag, Stuttgart, New York
12. Mayer NH, Esquenazi A, Keenan MAE (1996) Analysis and management of spasticity, contracture, and impaired motor control. In: Horn LJ, Zasler ND (eds) Medical rehabilitation of traumatic brain injury. Hanley & Belfus, Inc, Philadelphia, pp 411-458
13. Meythaler JM, De Vivo MJ, Hadley M (1996) Prospective study on the use of bolus intrathecal baclofen for spastic hypertonia due to acquired brain injury. Arch Phys Med Rehabil 77: 461-466
14. Meythaler JM, Guin-Renfroe S, Brunner RC, Hadley MN (2001) Intrathecal baclofen for spastic hypertonia from stroke. Stroke 32:2099-2109
15. Ochs GA, Reimann IW (1995) Baclofen intrathekal. Georg Thieme, Stuttgart New York
16. Pandyan AD, Johnson GR, Price CI, Curless RH, Barnes MP, Rodgers H (1999) A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity. Clin Rehabil 13:373-383
17. Pinedo S, de la Villa FM (2001 ) Complicaciones en el paciente hemiplejico durante el primer ano tras el ictus. Rev Neurol (Paris) 32:206-209
18. Pohl M, Rockstroh G, Rückriem S, Mehrholz J, Mrass G, Pause M (2002) Measurement of the effect of a bolus dose of intrathecal baclofen by continuous measurement of force under fibreglass casts. J Neurol 249:1254-1262
19. Pohl M, Rückriem S, Mehrholz J, Ritschel C, Strik H, Pause M (2002) Effectiveness of serial casting in patients with severe cerebral spasticity: a comparison study. Arch Phys Med Rehabil 83:784-790
20. Rushton DN (2001) Intrathecal baclofen for control of spinal and supraspinal spasticity. In: Barnes MP, Johnson GR (eds) Upper motor neurone syndrome and spasticity: Clinical management and neurophysiology. Cambridge University Press, Cambridge, pp 223-238
21. Sallerin-Caute B, Lazorthes Y, Monsarrat B, Cros J, Bastide R (1991) CSF baclofen levels after intrathecal administration in severe spasticity. Eur J Clin Pharmacol 40:363-365
22. Sheean G (2001 ) Neurophysiology of spasticity. In: Barnes MP, Johnson GR (eds) Upper motor neurone syndrome and spasticity: Clinical management and neurophysiology. Cambridge University Press, Cambridge, pp 12-78
23. Tauber ES, Coleman RM, Weitzman ED (1977) Absence of tonic electromyographic activity during sleep in normal and spastic nonmimetic skeletal muscles in man. Ann Neurol 2:66-68
24. Van Schaeybroeck P, Nuttin B, Lagae L, Schrijvers E, Borghgraef C, Feys P (2000) Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study. Neurosurgery 46:603-609; discussion 609-612
25. Yarkony GM, Sahgal V (1987) Contractures. A major complication of cranio-cerebral trauma. Clin Orthop 219: 93-96